DNA Vaccination: Transfection and Activation of Dendritic Cells as Key Events for Immunity
Open Access
- 4 January 1999
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 189 (1) , 169-178
- https://doi.org/10.1084/jem.189.1.169
Abstract
The mechanisms underlying initiation and maintenance of CD4 T cell responses after DNA vaccination were studied using a construct coding for nonsecreted fifth component of complement (C5) protein, thus restricting the availability of antigen. The only cell types to express C5 were keratinocytes at the site of DNA application and a small number of dendritic cells present in the draining lymph nodes. Antigen expression persisted for up to 12 wk in keratinocytes, but dendritic cells did not express C5 beyond 2 wk after vaccination. Cross-priming of dendritic cells by C5 expressed in keratinocytes did not occur unless keratinocyte death was induced by irradiation in vitro. CD4 T cells were activated in the draining lymph nodes only and subsequently migrated to the spleen, where memory T cells persisted for longer than 40 wk despite the absence of a source of persistent antigen. While DNA vaccination resulted in transfection of a small proportion of dendritic cells only, it led to general activation of all dendritic cells, thus providing optimal conditions for effective T cell activation and maintenance of memory.Keywords
This publication has 36 references indexed in Scilit:
- Excessive degradation of intracellular protein in macrophages prevents presentation in the context of major histocompatibility complex class II moleculesEuropean Journal of Immunology, 1997
- DNA VACCINESAnnual Review of Immunology, 1997
- Immune Activation by Bacterial DNA: A New Genetic CodeImmunity, 1996
- B cells solicit their own help from T cells.The Journal of Experimental Medicine, 1996
- Limited capacity for tolerization of CD4+ T cells specific for a pancreatic β cell neo-antigenImmunity, 1995
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995
- Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor AntigensScience, 1994
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.The Journal of Experimental Medicine, 1994
- The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies.The Journal of Experimental Medicine, 1990
- Direct Gene Transfer into Mouse Muscle in VivoScience, 1990